Effect of Anti‐VEGF Therapy on the Disease Progression of Neovascular Age‐Related Macular Degeneration: A Systematic Review and Model‐Based Meta‐Analysis

Anti–vascular endothelial growth factor (VEGF) therapy is used to slow the disease progression of neovascular age‐related macular degeneration. Due to the treatment burden of frequent intravitreal injections, anti‐VEGFs are often used on treat and extend protocols rather than the labeled frequency....

Descripción completa

Detalles Bibliográficos
Autores principales: Luu, Kenneth T., Seal, Jennifer, Green, Michelle, Winskill, Carolyn, Attar, Mayssa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305109/
https://www.ncbi.nlm.nih.gov/pubmed/34783362
http://dx.doi.org/10.1002/jcph.2002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305109/
https://www.ncbi.nlm.nih.gov/pubmed/34783362
http://dx.doi.org/10.1002/jcph.2002

Ejemplares similares